A pilot study of low-cost, high-resolution microendoscopy as a tool for identifying women with cervical precancer

Cancer Prevention Research

Volumn 5, Issue 11, 2012, Pages 1273-1279

  Pierce, Mark C ^a   Guan, YaoYao ^b   Quinn, Mary Kate ^c   Zhang, Xun ^d   Zhang, Wen Hua ^d   Qiao, You Lin ^d   Castle, Philip ^e   Richards Kortum, Rebecca ^c  

^a RUTGERS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Rice University   (United States)

^d CANCER HOSPITAL   (China)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; VIRUS DNA;

ADULT; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER SCREENING; CELL STRUCTURE; COLPOSCOPY; ENDOSCOPY; EPITHELIUM CELL; FEMALE; HEALTH CARE COST; HIGH RESOLUTION MICROENDOSCOPY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; TUMOR BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; ALGORITHMS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; HYSTEROSCOPY; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PILOT PROJECTS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84870234104     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-12-0221     Document Type: Article

References (21)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon, France: International Agency for Research on Cancer; 2010. [cited 2012 Jan 17]; Available from: http://globocan.iarc.fr.
2. Boyle P, Levin B, editors. World Cancer Report 2008. Lyon, France: International Agency for Research on Cancer; 2008.
3. Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynecol Obstet 2005;89:Suppl 2:S4-12.
4. Denny L, Kuhn L, Pollack A, Wright TC Jr. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer 2002;94:1699-707. (Pubitemid 34241107)
5. Sauvaget C, Fayette J-M, Muwonge R, Wesley R, Sankaranarayanan R. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet 2011;113:14-24.
6. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahé C, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005;353:2158-68. (Pubitemid 41653107)
7. Cronjé HS, Parham GP, Cooreman BF, de Beer A, Divall P, Bam RH. A comparison of four screening methods for cervical neoplasia in a developing country. Am J Obstet Gynecol 2003;188:395-400. (Pubitemid 36249977)
8. Thekkek N, Richards-Kortum R. Optical imaging for cervical cancer detection: solutions for a continuing global problem. Nat Rev Cancer 2008;8:725-31.
9. Georgakoudi I, Sheets EE, Müller MG, Backman V, Crum CP, Badizadegan K, et al. Trimodal spectroscopy for the detection and characterization of cervical precancers in vivo. Am J Obstet Gynecol 2002;186:374-82. (Pubitemid 34234144)
10. Chang VT-C, Cartwright PS, Bean SM, Palmer GM, Bentley RC, Ramanujam N. Quantitative physiology of the precancerous cervix in vivo through optical spectroscopy. Neoplasia 2009;11:325-32.
11. Pierce MC, Javier DJ, Richards-Kortum R. Optical contrast agents and imaging systems for detection and diagnosis of cancer. Int J Cancer 2008;123:1979-90.
12. Sung K-B, Richards-Kortum R, Follen M, Malpica A, Liang C, Descour MR. Fiber optic confocal reflectance microscopy: A new real-time technique to view nuclear morphology in cervical squamous epithelium in vivo. Opt Express 2003;11:3171-81.
13. Tan J, Quinn MA, Pyman JM, Delaney PM, McLaren WJ. Detection of cervical intraepithelial neoplasia in vivo using confocal endomicroscopy. BJOG 2009;116:1663-70.
14. Pierce MC, Yu D, Richards-Kortum R. High-resolution fiber-optic microendoscopy for in situ cellular imaging. JOVE 2011;47:e2306.
15. Gravitt PE, Coutlée F, Iftner T, Sellors JW, Quint WGV, Wheeler CM. New technologies in cervical cancer screening. Vaccine 2008;26S:K42-K52.
16. Schiffman M, Castle PE. The promise of global cervical-cancer prevention. N Engl J Med 2005;353:2101-4. (Pubitemid 41653100)
17. Shin D, Pierce MC, Gillenwater AM, Williams MD, Richards-Kortum RR. A fiber-optic fluorescence microscope using a consumer-grade digital camera for in vivo cellular imaging. PLoS One 2010;5:e11218.
18. Muldoon TJ, Thekkek N, Roblyer D, Maru D, Harpaz N, Potack J, et al. Evaluation of quantitative image analysis criteria for the high-resolution microendoscopic detection of neoplasia in Barrett's esophagus. J Biomed Opt 2010;15:026027.
19. Muldoon TJ, Roblyer D, Williams MD, Stepanek VMT, Richards-Kortum R, Gillenwater AM. Noninvasive imaging of oral neoplasia with a high-resolution fiber-optic microendoscope. Head Neck 2012;34:305-12.
20. Agosti JM, Goldie SJ. Introducing HPV vaccine in developing countries - Key challenges and issues. N Engl J Med 2007;356:1908-10. (Pubitemid 46740300)
21. Roden R, Wu T-C. How will HPV vaccines affect cervical cancer? Nat Rev Cancer 2006;6:753-63. (Pubitemid 44450464)